Trial Profile
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2021
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Coronary artery disease; Coronary stent thrombosis
- Focus Therapeutic Use
- Acronyms ADAPT-DES
- 30 Mar 2020 Results (n=254) of two years assessing effects of high platelet reactivity on clinical outcomes after revascularization for left main coronary artery disease presented at the 2020 Annual Scientific Session of the American College of Cardiology and World Congress of Cardiology
- 09 Dec 2019 Results determining the relation between age and platelet reactivity on 2-year outcomes after percutaneous coronary intervention with drug-eluting stents (DES) published in the American Journal of Cardiology
- 07 Aug 2019 Results published in the American Journal of Cardiology.